Identification and characterization of RTVP1/GLIPR1-like genes, a novel p53 target gene cluster

Genomics

Volumn 88, Issue 2, 2006, Pages 163-172

  Ren, Chengzhen ^a   Ren, Cheng Hui ^a   Li, Likun ^a   Goltsov, Alexei A ^a   Thompson, Timothy C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder cancer; GLIPR1; GLIPR1L1; GLIPR1L2; p53 target genes; Prostate cancer; RTVP1; RTVP1 GLIPR1 gene cluster

Indexed keywords

PROTEIN P53;

AMINO ACID SEQUENCE; ARTICLE; CHROMOSOME 10; CHROMOSOME 12Q; CONTROLLED STUDY; GENE; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; GENETIC ANALYSIS; GLIOMA PATHOGENESIS RELATED PROTEIN 1 GENE; HUMAN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RELATED TO TESTES SPECIFIC VESPID AND PATHOGENESIS PROTEIN 1 GENE; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; HUMANS; MALE; MICE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SPECIES SPECIFICITY; TESTIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33745964655     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2006.03.021     Document Type: Article

References (41)

1. Burns T.F., and el-Deiry W.S. The p53 pathway and apoptosis. J. Cell. Physiol. 181 (1999) 231-239
2. el-Deiry W.S. Regulation of p53 downstream genes. Semin. Cancer Biol. 8 (1998) 345-357
3. Hofseth L.J., Hussain S.P., and Harris C.C. p53:25 years after its discovery. Trends Pharmacol. Sci. 25 (2004) 177-181
4. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
5. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 (1997) 300-305
6. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C. p53 mutations in human cancers. Science 253 (1991) 49-53
7. Stapleton A.M., et al. Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases. Clin. Cancer Res. 3 (1997) 1389-1397
8. Thompson T.C., et al. Loss of p53 function leads to metastasis in ras + myc-initiated mouse prostate cancer. Oncogene 10 (1995) 869-879
9. Vogelstein B., and Kinzler K.W. p53 function and dysfunction. Cell 70 (1992) 523-526
10. Navone N.M., et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J. Natl. Cancer Inst. 85 (1993) 1657-1669
11. Eastham J.A., et al. Association of p53 mutations with metastatic prostate cancer. Clin. Cancer Res. 1 (1995) 1111-1118
12. Murphy E.V., Zhang Y., Zhu W., and Biggs J. The human glioma pathogenesis-related protein is structurally related to plant pathogenesis-related proteins and its gene is expressed specifically in brain tumors. Gene 159 (1995) 131-135
13. Rich T., Chen P., Furman F., Huynh N., and Israel M.A. RTVP-1, a novel human gene with sequence similarity to genes of diverse species, is expressed in tumor cell lines of glial but not neuronal origin. Gene 180 (1996) 125-130
14. Gingras M.C., and Margolin J.F. Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hybridization. Exp. Hematol. 28 (2000) 65-76
15. Henriksen A., et al. Major venom allergen of yellow jackets, Ves v 5: structural characterization of a pathogenesis-related protein superfamily. Proteins 45 (2001) 438-448
16. Kovalick G.E., and Griffin D.L. Characterization of the SCP/TAPS gene family in Drosophila melanogaster. Insect Biochem. Mol. Biol. 35 (2005) 825-835
17. + channel inhibitor-like fold. J. Biol. Chem. 280 (2005) 12405-12412
18. Shikamoto Y., Suto K., Yamazaki Y., Morita T., and Mizuno H. Crystal structure of a CRISP family Ca(2+)-channel blocker derived from snake venom. J. Mol. Biol. 350 (2005) 735-743
19. Busso D., Cohen D.J., Hayashi M., Kasahara M., and Cuasnicu P.S. Human testicular protein TPX1/CRISP-2: localization in spermatozoa, fate after capacitation and relevance for gamete interaction. Mol. Hum. Reprod. 11 (2005) 299-305
20. Kitajima S., and Sato F. Plant pathogenesis-related proteins: molecular mechanisms of gene expression and protein function. J. Biochem. (Tokyo) 125 (1999) 1-8
21. Nobile M., Noceti F., Prestipino G., and Possani L.D. Helothermine, a lizard venom toxin, inhibits calcium current in cerebellar granules. Exp. Brain Res. 110 (1996) 15-20
22. Szyperski T., et al. Structure comparison of human glioma pathogenesis-related protein GliPR and the plant pathogenesis-related protein P14a indicates a functional link between the human immune system and a plant defense system. Proc. Natl. Acad. Sci. USA 95 (1998) 2262-2266
23. Udby L., et al. Cysteine-rich secretory protein 3 is a ligand of alpha1B-glycoprotein in human plasma. Biochemistry 43 (2004) 12877-12886
24. Ren C., et al. mRTVP-1, a novel p53 target gene with proapoptotic activities. Mol. Cell. Biol. 22 (2002) 3345-3357
25. Ren C., et al. RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer. Cancer Res. 64 (2004) 969-976
26. Satoh T., et al. Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer. Hum. Gene Ther. 14 (2003) 91-101
27. Eberle H.B., et al. Identification and characterization of a novel human plant pathogenesis-related protein that localizes to lipid-enriched microdomains in the Golgi complex. J. Cell Sci. 115 (2002) 827-838
28. Serrano R.L., et al. Structural analysis of the human Golgi-associated plant pathogenesis related protein GAPR-1 implicates dimerization as a regulatory mechanism. J. Mol. Biol. 339 (2004) 173-183
29. Shyamsundar R., et al. A DNA microarray survey of gene expression in normal human tissues. Genome Biol. 6 (2005) R22
30. el-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., and Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1 (1992) 45-49
31. Wang W., Rastinejad F., and el-Deiry W.S. Restoring p53-dependent tumor suppression. Cancer Biol. Ther. 2 (2003) S55-S63
32. Stilgenbauer S., and Dohner H. Molecular genetics and its clinical relevance. Hematol. Oncol. Clin. North Am. 18 (2004) 827-848
33. Hollstein M., et al. New approaches to understanding p53 gene tumor mutation spectra. Mutat. Res. 431 (1999) 199-209
34. Haupt Y., Maya R., Kazaz A., and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387 (1997) 296-299
35. Momand J., Zambetti G.P., Olson D.C., George D., and Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69 (1992) 1237-1245
36. Kubbutat M.H., Jones S.N., and Vousden K.H. Regulation of p53 stability by Mdm2. Nature 387 (1997) 299-303
37. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., and Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358 (1992) 80-83
38. Gao X., Porter A.T., and Honn K.V. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer: therapeutic implications. Adv. Exp. Med. Biol. 407 (1997) 41-53
39. Mullauer L., et al. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat. Res. 488 (2001) 211-231
40. Eisenberg I., Barash M., Kahan T., and Mitrani-Rosenbaum S. Cloning and characterization of a human novel gene C9orf19 encoding a conserved putative protein with an SCP-like extracellular protein domain. Gene 293 (2002) 141-148
41. Baker S.J., Markowitz S., Fearon E.R., Willson J.K., and Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249 (1990) 912-915